Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
1.
Emerg Med Clin North Am ; 41(3): 413-432, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37391242

ABSTRACT

Lay rescuers play a pivotal role in the recognition and initial management of out-of-hospital cardiac arrest. The provision of timely pre-arrival care by lay responders, including cardiopulmonary resuscitation and the use of automated external defibrillator before emergency medical service arrival, is important link in the chain of survival and has been shown to improve outcomes from cardiac arrest. Although physicians are not directly involved in bystander response to cardiac arrest, they play a key role in emphasizing the importance of bystander interventions.


Subject(s)
Cardiopulmonary Resuscitation , Emergency Medical Services , Out-of-Hospital Cardiac Arrest , Physicians , Humans , Out-of-Hospital Cardiac Arrest/therapy
3.
JAMA Netw Open ; 3(11): e2024596, 2020 11 02.
Article in English | MEDLINE | ID: mdl-33196806

ABSTRACT

Importance: Saline (0.9% sodium chloride), the fluid most commonly used to treat diabetic ketoacidosis (DKA), can cause hyperchloremic metabolic acidosis. Balanced crystalloids, an alternative class of fluids for volume expansion, do not cause acidosis and, therefore, may lead to faster resolution of DKA than saline. Objective: To compare the clinical effects of balanced crystalloids with the clinical effects of saline for the acute treatment of adults with DKA. Design, Setting, and Participants: This study was a subgroup analysis of adults with DKA in 2 previously reported companion trials-Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department (SALT-ED) and the Isotonic Solutions and Major Adverse Renal Events Trial (SMART). These trials, conducted between January 2016 and March 2017 in an academic medical center in the US, were pragmatic, multiple-crossover, cluster, randomized clinical trials comparing balanced crystalloids vs saline in emergency department (ED) and intensive care unit (ICU) patients. This study included adults who presented to the ED with DKA, defined as a clinical diagnosis of DKA, plasma glucose greater than 250 mg/dL, plasma bicarbonate less than or equal to 18 mmol/L, and anion gap greater than 10 mmol/L. Data analysis was performed from January to April 2020. Interventions: Balanced crystalloids (clinician's choice of Ringer lactate solution or Plasma-Lyte A solution) vs saline for fluid administration in the ED and ICU according to the same cluster-randomized multiple-crossover schedule. Main Outcomes and Measures: The primary outcome was time between ED presentation and DKA resolution, as defined by American Diabetes Association criteria. The secondary outcome was time between initiation and discontinuation of continuous insulin infusion. Results: Among 172 adults included in this secondary analysis of cluster trials, 94 were assigned to balanced crystalloids and 78 to saline. The median (interquartile range [IQR]) age was 29 (24-45) years, and 90 (52.3%) were women. The median (IQR) volume of isotonic fluid administered in the ED and ICU was 4478 (3000-6372) mL. Cumulative incidence analysis revealed shorter time to DKA resolution in the balanced crystalloids group (median time to resolution: 13.0 hours; IQR: 9.5-18.8 hours) than the saline group (median: 16.9 hours; IQR: 11.9-34.5 hours) (adjusted hazard ratio [aHR] = 1.68; 95% CI, 1.18-2.38; P = .004). Cumulative incidence analysis also revealed shorter time to insulin infusion discontinuation in the balanced crystalloids group (median: 9.8 hours; IQR: 5.1-17.0 hours) than the saline group (median: 13.4 hours; IQR: 11.0-17.9 hours) (aHR = 1.45; 95% CI, 1.03-2.03; P = .03). Conclusions and Relevance: In this secondary analysis of 2 cluster randomized clinical trials, compared with saline, treatment with balanced crystalloids resulted in more rapid resolution of DKA, suggesting that balanced crystalloids may be preferred over saline for acute management of adults with DKA. Trial Registration: ClinicalTrials.gov Identifiers: NCT02614040; NCT02444988.


Subject(s)
Crystalloid Solutions/therapeutic use , Diabetic Ketoacidosis/drug therapy , Fluid Therapy/statistics & numerical data , Saline Solution, Hypertonic/therapeutic use , Acidosis/chemically induced , Acidosis/prevention & control , Adult , Cluster Analysis , Cross-Over Studies , Crystalloid Solutions/adverse effects , Diabetic Ketoacidosis/blood , Diabetic Ketoacidosis/diagnosis , Electrolytes/blood , Emergency Service, Hospital/statistics & numerical data , Female , Fluid Therapy/methods , Humans , Infusions, Intravenous/methods , Insulin/administration & dosage , Insulin/therapeutic use , Intensive Care Units/statistics & numerical data , Isotonic Solutions/administration & dosage , Isotonic Solutions/adverse effects , Male , Middle Aged , Outcome Assessment, Health Care , Saline Solution, Hypertonic/adverse effects , Time Factors
4.
Am J Emerg Med ; 38(10): 2065-2069, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33142176

ABSTRACT

COVID-19 has caused global dramatic change in medical practices including the introduction of temporary screening and assessment areas outside the footprint of the main hospital structures. Following the initial surge of patients with novel coronavirus (2019-nCoV) in the United States, our medical center rapidly designed and constructed an alternative assessment and treatment site in a converted parking garage deck for emergency department patients with suspected or confirmed 2019-nCoV. During the first month after opening, 651 patients were treated in this alternative assessment area including 54 patients who tested positive for 2019-nCoV. This accounted for 55% of the 98 patients with confirmed novel coronavirus (2019-nCoV) who were treated in our ED. This report provides a blueprint for the necessary steps, materials, labor needs and barriers, both anticipated and unanticipated, to rapidly construct an alternative ED treatment site during a pandemic.


Subject(s)
COVID-19/therapy , Emergency Service, Hospital/organization & administration , Hospital Design and Construction/methods , Emergency Service, Hospital/statistics & numerical data , Humans , Pandemics , Personnel Staffing and Scheduling/organization & administration , SARS-CoV-2 , Triage/methods
6.
J Am Med Inform Assoc ; 27(6): 967-971, 2020 06 01.
Article in English | MEDLINE | ID: mdl-32240303

ABSTRACT

Emergent policy changes related to telemedicine and the Emergency Medical Treatment and Labor Act during the novel coronavirus disease 2019 (COVID-19) pandemic have created opportunities for technology-based clinical evaluation, which serves to conserve personal protective equipment (PPE) and protect emergency providers. We define electronic PPE as an approach using telemedicine tools to perform electronic medical screening exams while satisfying the Emergency Medical Treatment and Labor Act. We discuss the safety, legal, and technical factors necessary for implementing such a pathway. This approach has the potential to conserve PPE and protect providers while maintaining safe standards for medical screening exams in the emergency department for low-risk patients in whom COVID-19 is suspected.


Subject(s)
Betacoronavirus , Coronavirus Infections/diagnosis , Emergency Medical Services/methods , Emergency Service, Hospital , Mass Screening/methods , Personal Protective Equipment , Pneumonia, Viral/diagnosis , Telemedicine , COVID-19 , Coronavirus Infections/epidemiology , Emergency Medical Services/legislation & jurisprudence , Government Regulation , Humans , Mass Screening/instrumentation , Mass Screening/legislation & jurisprudence , Pandemics , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Telemedicine/legislation & jurisprudence , United States
8.
Emerg Med Pract ; 22(2): 1-20, 2020 02.
Article in English | MEDLINE | ID: mdl-31978294

ABSTRACT

For patients presenting with suspected diabetic ketoacidosis (DKA) and the hyperosmolar hyperglycemic state (HHS) understanding of the etiology and pathophysiology will ensure optimal emergency management. Morbidity and mortality is most often due to the underlying precipitating cause, which may include infection, infarction/ischemia, noncompliance with insulin therapy, pregnancy, and dietary indiscretion. Current guidelines are based primarily on expert opinion and consensus statements, but more recent evidence suggests that recommendations related to arterial blood gas, insulin bolus, and IV fluid replacement should be re-evaluated. This issue presents an approach to DKA and HHS management based on current evidence, with a simplified pathway for emergency department management.


Subject(s)
Fluid Therapy/methods , Hyperglycemia/physiopathology , Diabetes Complications/drug therapy , Diabetes Complications/physiopathology , Diabetes Mellitus/drug therapy , Diabetic Ketoacidosis/drug therapy , Diabetic Ketoacidosis/physiopathology , Humans , Hyperglycemia/drug therapy , Hyperglycemic Hyperosmolar Nonketotic Coma/drug therapy , Hyperglycemic Hyperosmolar Nonketotic Coma/physiopathology , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use
10.
Acad Emerg Med ; 25(10): 1157-1163, 2018 10.
Article in English | MEDLINE | ID: mdl-29799649

ABSTRACT

OBJECTIVES: With the rise of opioid use in the United States, the increasing demand for treatment for opioid use disorders presents both a challenge and an opportunity to develop new care pathways for emergency department (ED) patients seeking opioid detoxification. We set out to improve the care of patients presenting to our ED seeking opioid detoxification by implementing a standardized management pathway and to measure the effects of this intervention. METHODS: We conducted a before-after study of the effects of an opioid detoxification management pathway on ED length of stay (EDLOS), use of resources (social worker consultation, laboratory tests obtained), and return visits to the same ED within 30 days of discharge. All data were collected retrospectively by review of the electronic health record. RESULTS: Ultimately, 107 patients presented to the ED that met criteria, 52 in the intervention period and 55 in the preintervention period. Median EDLOS in the intervention period was 152 (interquartile range [IQR] = 93-237) minutes compared to 312 (IQR = 187-468) minutes in the preintervention period (p < 0.001). Patients in the intervention period less frequently had a social work consultation (32.7% vs. 83.6%, p < 0.001) or had laboratory tests obtained (32.7% vs 74.5%, p < 0.001) and more frequently were prescribed a medication for withdrawal symptoms (57.7% vs. 29.1%, p = 0.003). CONCLUSIONS: Implementation of an opioid detoxification management pathway reduced EDLOS, reduced utilization of resources, and increased the proportion of patients prescribed medications for symptom relief.


Subject(s)
Emergency Service, Hospital/organization & administration , Length of Stay/statistics & numerical data , Opioid-Related Disorders/therapy , Adult , Critical Pathways/organization & administration , Female , Humans , Male , Middle Aged , Retrospective Studies , United States
11.
N Engl J Med ; 378(9): 819-828, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29485926

ABSTRACT

BACKGROUND: Comparative clinical effects of balanced crystalloids and saline are uncertain, particularly in noncritically ill patients cared for outside an intensive care unit (ICU). METHODS: We conducted a single-center, pragmatic, multiple-crossover trial comparing balanced crystalloids (lactated Ringer's solution or Plasma-Lyte A) with saline among adults who were treated with intravenous crystalloids in the emergency department and were subsequently hospitalized outside an ICU. The type of crystalloid that was administered in the emergency department was assigned to each patient on the basis of calendar month, with the entire emergency department crossing over between balanced crystalloids and saline monthly during the 16-month trial. The primary outcome was hospital-free days (days alive after discharge before day 28). Secondary outcomes included major adverse kidney events within 30 days - a composite of death from any cause, new renal-replacement therapy, or persistent renal dysfunction (defined as an elevation of the creatinine level to ≥200% of baseline) - all censored at hospital discharge or 30 days, whichever occurred first. RESULTS: A total of 13,347 patients were enrolled, with a median crystalloid volume administered in the emergency department of 1079 ml and 88.3% of the patients exclusively receiving the assigned crystalloid. The number of hospital-free days did not differ between the balanced-crystalloids and saline groups (median, 25 days in each group; adjusted odds ratio with balanced crystalloids, 0.98; 95% confidence interval [CI], 0.92 to 1.04; P=0.41). Balanced crystalloids resulted in a lower incidence of major adverse kidney events within 30 days than saline (4.7% vs. 5.6%; adjusted odds ratio, 0.82; 95% CI, 0.70 to 0.95; P=0.01). CONCLUSIONS: Among noncritically ill adults treated with intravenous fluids in the emergency department, there was no difference in hospital-free days between treatment with balanced crystalloids and treatment with saline. (Funded by the Vanderbilt Institute for Clinical and Translational Research and others; SALT-ED ClinicalTrials.gov number, NCT02614040 .).


Subject(s)
Acute Disease/therapy , Electrolytes/therapeutic use , Emergency Treatment , Fluid Therapy , Isotonic Solutions/therapeutic use , Sodium Chloride/therapeutic use , Acute Disease/mortality , Adult , Aged , Cross-Over Studies , Electrolytes/blood , Emergency Service, Hospital , Female , Hospitalization , Humans , Kidney Diseases/mortality , Kidney Diseases/therapy , Male , Middle Aged , Renal Replacement Therapy , Ringer's Lactate
12.
Acad Emerg Med ; 25(1): 65-75, 2018 01.
Article in English | MEDLINE | ID: mdl-28940546

ABSTRACT

BACKGROUND: Emergency department (ED) acuity is the general level of patient illness, urgency for clinical intervention, and intensity of resource use in an ED environment. The relative strength of commonly used measures of ED acuity is not well understood. METHODS: We performed a retrospective cross-sectional analysis of ED-level data to evaluate the relative strength of association between commonly used proxy measures with a full spectrum measure of ED acuity. Common measures included the percentage of patients with Emergency Severity Index (ESI) scores of 1 or 2, case mix index (CMI), academic status, annual ED volume, inpatient admission rate, percentage of Medicare patients, and patients seen per attending-hour. Our reference standard for acuity is the proportion of high-acuity charts (PHAC) coded and billed according to the Centers for Medicare and Medicaid Service's Ambulatory Payment Classification (APC) system. High-acuity charts included those APC 4 or 5 or critical care. PHAC was represented as a fractional response variable. We examined the strength of associations between common acuity measures and PHAC using Spearman's rank correlation coefficients (rs ) and regression models including a quasi-binomial generalized linear model and linear regression. RESULTS: In our univariate analysis, the percentage of patients ESI 1 or 2, CMI, academic status, and annual ED volume had statistically significant associations with PHAC. None explained more than 16% of PHAC variation. For regression models including all common acuity measures, academic status was the only variable significantly associated with PHAC. CONCLUSION: Emergency Severity Index had the strongest association with PHAC followed by CMI and annual ED volume. Academic status captures variability outside of that explained by ESI, CMI, annual ED volume, percentage of Medicare patients, or patients per attending per hour. All measures combined only explained only 42.6% of PHAC variation.


Subject(s)
Emergency Service, Hospital/statistics & numerical data , Patient Acuity , Cross-Sectional Studies , Humans , Insurance, Health/statistics & numerical data , Retrospective Studies , Triage/statistics & numerical data , United States
14.
SELECTION OF CITATIONS
SEARCH DETAIL
...